Interview: Quality First!

micheal-eder

Michael Eder

November 27, 2021

Table of contents

Show

Biopharma offers a field of many potential obstacles and pitfalls. One of them is without a doubt the topic around Qualification, Validation & GMP-Compliance.
Elisabeth Haas-Karagiannidis, Head of Quality Management and Validation at Single Use Support, has given some insights in the course of Single Use Support’s podcast series.

Qualification and Validation – why is it such a big issue?

Demonstrating that the equipment is suitable for its intended use by qualification & validation is a mandatory requirement for pharmaceutical industry by authorities. Depending on complexity of systems and risk for product, it can mean a lot of effort. Companies often underestimate the workload accompanied with qualification and end up exceeding project due dates.

How does such a qualification & validation process look like in theory?

It starts with defining the specific requirements of the equipment of interest. The customer needs to define for example on materials and surfaces, and for systems with software on electronic records and data integrity. Also, with regards to regulatory requirements this needs to be considered. Once the requirements are specified in detail and the functional design is agreed on, the machine can be built.
Once built, it is all about testing. Testing is based on the specifications set in design phase. The extent of testing and the assignment to a testing phase is to be done by a risk-based approach, which emphasizes the focus on critical potential threats.

It is common practice that engineering companies offer a basic testing approach, the so-called FAT and SAT. But why has SUS decided to offer services beyond that?

The reason is simply that we want to offer end-to-end solutions. Let me explain: FAT and SAT [factory & site acceptance test] are mainly focusing on critical technical and mechanical aspects, so what we as a manufacturer need to make sure that our product works properly. But the pharma companies need more, in order to finally release the equipment for operational use in a GMP environment. There is additional testing required to verify for example customer-specific configurations, and performance related to a customer-specific process, or tests related to 21 CFR part 11 compliance.
In a nutshell, we do not want to leave our customer alone half-way, we offer the full carefree package from purchase order to release for operations and beyond.

According to your experience, what services are required from your current customers with regards to qualification/validation?

Our customers appreciate very much the services we offer beyond standard testing. We are able to adapt testing procedures to meet the customer’s needs, for example verification runs tailored to verify their specific manufacturing process, which makes qualification and validation services really fully leverageable, meaning that the customer does not need to do further testing internally. I would even name it “next-level leveraging”.

When a customer obtains technologies by Single Use Support, would it also be possible to outsource the whole qualification/validation?

Sure, no worries! It is possible to rely on our experience and let us deliver the whole package. The customer can benefit from the experience of our product experts and additionally make sure that timelines are met for sure.

Fill the Form below and download our Qualification FAQ Sheet:

Single Use Support Qualification Validation FAQ

Qualification & Validation FAQ Sheet
micheal-eder

Michael Eder

Senior Marketing Manager

Michael Eder, MA, is Senior Marketing Manager at Single Use Support. He is expert in pharma and health communication with his 10+ years experience in pharma. After completing his master's degree in International Healthcare Management at MCI The Entrepreneurial school in Innsbruck, he has gained experience in the pharmaceutical field manufacturing and commercialization of OTC and RX drugs. Michael creates articles about Freeze Thaw applications and Platform solutions from Single Use Support and is the author of current news with Single Use Support worldwide. 

More from Michael Eder

News

Single Use Support honoured as one of the ‘Best Managed Companies’

Deloitte Austria and Raiffeisenlandesbank Niederösterreich-Wien have honoured outstandingly managed companies. Single Use Support was the only winner from Tyrol to be honoured with the title ‘Best Managed Company 2024’. 

micheal-eder

Michael Eder

September 30, 2024

News

Third consecutive Pharma Innovation Award for Single Use Support

RoSS.PADL, the homogenizing solution from Single Use Support, was awarded the 2024 Innovation Award by Pharma Manufacturing.

micheal-eder

Michael Eder

September 26, 2024

Read more about Biopharma

Biopharma

Annex 1: All you need to know

Annex 1 is a fundamental framework for the production of sterile medicinal goods. This article will provide an overview of the concept, its history, contents, challenges, and perspectives.

michael-muehlegger

Michael Mühlegger

March 20, 2024

Biopharma

Top 7 pharmaceutical CDMOs in 2024

Progress in the pharmaceutical industry is significantly driven by CDMOs, collaborating with pharma companies. In this article, we will put 7 outstanding CDMOs in the spotlight.

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

CMO vs. CDMO: What are the differences?

Both CMOs and CDMOs are frequently relied on partners in the pharmaceutical industry. But what sets them apart, where are their strengths, and what do they offer?

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

Start Pharma 4.0: Examples to Advance Ultra-Cold Storage of Drug Substances

Innovative manufacturers are striving for operational excellence in as many areas of bioprocessing as possible. In return,a standardized and fully automated processes contribute to cost efficiency, patient safety, and sustainability in biomanufacturing. 

Alexander Fuchs | Single Use Support

Alexander Fuchs

September 4, 2023